Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related RSV ...

Adults who get sick with the seasonal virus RSV have a higher risk of serious cardiovascular complications, making vaccination especially protective. For adults 45 and older, RSV raises the risk of ...

Almost 70 years after the discovery of the respiratory syncytial virus (RSV), vaccines and preventive treatments are giving babies a chance to beat the potentially deadly childhood infection. As ...

Amid a surprisingly severe flu season and a COVID-19 resurgence, those highly contagious respiratory illnesses are drawing the largest share of media coverage and public attention. But it is also the ...

As fall approaches, so does respiratory syncytial virus or RSV season. This year, there are more options for those most susceptible to RSV, including a new vaccine and updated RSV vaccine guidance for ...

Use of nirsevimab was associated with an approximately 80% reduction in illness due to respiratory syncytial virus (RSV) infections among American Indian and Alaskan Native (AI/AN) infants, based on ...

Scientists in China have developed a two-antibody cocktail to treat respiratory syncytial virus, or RSV, that in laboratory studies prevented the virus from developing drug resistance—a persistent ...

Major U.S. medication organizations recently issued guidance on who they think should receive COVID, flu, and RSV ...

In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can ...

The season of never-ending sneezing and stuffy noses is underway, sending Americans to pharmacy lines in hopes of keeping illness at bay with yearly shots. While flu and COVID-19 vaccines are an ...